Dermapharm Holding SE sell Biotechhunter
Start price
28.10.20
/
50%
€41.19
Target price
04.11.21
-
Performance (%)
62.18%
End price
15.07.21
€66.80
Summary
This prediction ended on 15.07.21 with a price of €66.80. The price for Dermapharm Holding SE massively increased, which is bad news for the SELL prediction by Biotechhunter. Biotechhunter has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 0.243% | 0.243% | -1.316% | 12.828% |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% | 57.846% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% | 84.823% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% | 54.805% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% | 64.029% |
Comments by Biotechhunter for this prediction
In the thread Dermapharm Holding SE diskutieren
Sell Dermapharm Holding SE